Companies
McKesson Corporation
S&P 500Health Care· USA

MCK

Status-Quo-Player

McKesson Corporation

$864.57

-0.15%

Open $865.47·Prev $865.84

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

pharmaceuticals must flow to reach patients.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Compounding Through Mix Shift, Specialty Growth, and Buybacks

ROC 200

+22.9%

Company Profile

McKesson Corporation is a leading diversified healthcare services company specializing in pharmaceutical distribution and supply chain management solutions. It operates primarily through key segments including North American Pharmaceutical, which sources and distributes branded, generic, and specialty drugs to retail pharmacies, hospital networks, and healthcare providers; Oncology & Multispecialty, focusing on provider and specialty distribution growth; Prescription Technology Solutions, offering third-party logistics and technology services for pharmacies; and Medical-Surgical Solutions, supplying medical products and equipment to healthcare facilities. McKesson also engages in pharmaceutical wholesale in Canada and provides technology solutions enhancing access and efficiency in healthcare delivery. As one of three dominant players accounting for over 90% of the U.S. pharmaceutical wholesale market, alongside peers like Cencora and Cardinal Health, it partners with manufacturers, providers, pharmacies, and governments to ensure safe, timely, and cost-effective delivery of medicines and services. Founded in 1833 and headquartered in Irving, Texas, McKesson Corporation plays a critical role in the global healthcare ecosystem.

Sector

Healthcare

Industry

Medical Distribution

Employees

43,000

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.